143 related articles for article (PubMed ID: 31669397)
1. Hematopoietic Stem Cell Transplantation Without the Use of Blood Components by the Patient's Choice: Experience of 2 Brazilian Centers.
da Silva RL; da Silva LAM; Geraldo BLDSS; Simões AA; Almeida MSS; Fernandes PA; Simões CM; Russo FT; Okada LY; Cavalcante JN; Lopes MAVF; Macedo RA; Macedo MCMA
Biol Blood Marrow Transplant; 2020 Mar; 26(3):458-462. PubMed ID: 31669397
[TBL] [Abstract][Full Text] [Related]
2. A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem Cell Transplant.
Zhao JC; Arnall JR; Martin AL; Atrash S; Bhutani M; Voorhees P; Avalos B; Copelan E; Ghosh N; Hamadani M; Usmani S; Ford P
Biol Blood Marrow Transplant; 2019 Oct; 25(10):e305-e309. PubMed ID: 31295572
[TBL] [Abstract][Full Text] [Related]
3. Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience.
Elemary M; Seghatchian J; Stakiw J; Bosch M; Sabry W; Goubran H
Transfus Apher Sci; 2017 Jun; 56(3):317-321. PubMed ID: 28642120
[TBL] [Abstract][Full Text] [Related]
4. Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
Beck A; Lin R; Reza Rejali A; Rubens M; Paquette R; Vescio R; Merin N; Guerrero M; Federizo Y; Lua M; Uy L; Hernandez L; Allred M; Legaspi R; Leaverton M; Oliva S; Castillo R; Dean L; Bourke J; Cooper S; Gharapetian S; Causin J; Lopiccolo C; Ann Snoussi L; VanStrien P; Lill M; Linhares YP
Bone Marrow Transplant; 2020 Jun; 55(6):1059-1067. PubMed ID: 31898692
[TBL] [Abstract][Full Text] [Related]
5. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.
Coltoff A; Shreenivas A; Afshar S; Steinberg A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):44-49. PubMed ID: 30605629
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute leukaemia in adult Jehovah's Witnesses.
El Chaer F; Ballen KK
Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.
Shinohara A; Oshima K; Fuji S; Umeda K; Kako S; Kurokawa M; Tsukada N; Kasai M; Kondo T; Hashii Y; Nakamae H; Ikegame K; Kosaka Y; Shimada A; Nawa Y; Makoto Y; Yoshiko A; Fukuda T; Tanaka J; Ogata M
Biol Blood Marrow Transplant; 2020 Jan; 26(1):66-75. PubMed ID: 31494230
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of Mouse Model of H-2 Haploidentical Hematopoietic Stem Cell Transplantation from Double Donors].
Wang XN; Liang YM; Deng L; Wang L; Wang Y; Huang YJ; Liu TQ; Zuo HL; Hu KX; Qiao JH; Sun QY; Guo M; Ai HS; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):522-529. PubMed ID: 28446305
[TBL] [Abstract][Full Text] [Related]
9. Jehovah's Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies.
Park A; Rome S; Gantioque R
Clin J Oncol Nurs; 2019 Aug; 23(4):364-369. PubMed ID: 31322623
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in Saudi Arabia between 1984 and 2016: Experience from four leading tertiary care hematopoietic stem cell transplantation centers.
Shaheen M; Almohareb F; Aljohani N; Ayas M; Chaudhri N; Abosoudah I; Alotaibi S; Alshahrani M; Alsharif F; Akhtar S; Alhumaidan H; Rasheed W; Alfraih F; Al-Anazi K; Alhashmi H; Al-Daama S; Hanbali A; Alsaleh K; Alzahrani H; Ibrahim K; Alawwami M; Albeirouti B; Albeihany A; Alabdulwahab A; Motabi I; Zaidi SZA; Ahmed SO; Aljefri A; Hussain F; Alahmari A; Hashmi S; Elsolh H; Alseraihy A; Aljurf M
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):169-178. PubMed ID: 32888899
[TBL] [Abstract][Full Text] [Related]
11. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
12. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
[TBL] [Abstract][Full Text] [Related]
13. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Wang S
Transfusion; 2019 Nov; 59(11):3371-3385. PubMed ID: 31599972
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India.
Raj R; Aboobacker FN; Yadav SP; Uppuluri R; Bhat S; Choudhry D; Dua V; Kharya G; Rastogi N; Sachdev M; Khandelwal V; Swaminathan V; Bakane A; Ramakrishnan B; George B
Front Immunol; 2020; 11():606930. PubMed ID: 33488609
[TBL] [Abstract][Full Text] [Related]
15. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
[TBL] [Abstract][Full Text] [Related]
16. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
[TBL] [Abstract][Full Text] [Related]
17. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
18. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
[TBL] [Abstract][Full Text] [Related]
20. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]